Lamictal and lamotrigine are the same medication. Lamictal is the brand name, and lamotrigine is the generic name for the identical active ingredient. Every 100 mg tablet of generic lamotrigine contains exactly the same amount of drug as a 100 mg Lamictal tablet. The difference comes down to manufacturer, price, and a few inactive ingredients that don’t affect how the drug works for most people.
Brand Name vs. Generic Name
Lamictal was developed by GlaxoSmithKline and received FDA approval as the original branded product. Once that patent protection expired, other manufacturers began producing generic versions using the drug’s scientific name: lamotrigine. Your pharmacy may dispense either one depending on your insurance plan, and both are prescribed for the same conditions.
Lamotrigine is FDA-approved for two main uses. In epilepsy, it treats partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients aged 2 and older. It can also be used as a standalone treatment for partial-onset seizures in patients 16 and older. For bipolar I disorder, it’s approved as a maintenance treatment in adults to help delay mood episodes. It is not approved for bipolar disorder in anyone under 18.
How the FDA Ensures They Work the Same Way
Before a generic version of lamotrigine can reach the market, the manufacturer must prove it is bioequivalent to brand-name Lamictal. This means running a study where healthy volunteers take both versions, and blood levels of the drug are measured and compared. The FDA requires that the generic’s absorption profile falls within a tight statistical window of the brand-name product. If it doesn’t, the generic isn’t approved.
A large randomized trial called the EQUIGEN study put this to a rigorous test. Researchers took the two most different generic lamotrigine products on the U.S. market and switched epilepsy patients between them. The result: no loss of seizure control and no new side effects. The study provided the highest level of clinical evidence that FDA bioequivalence standards hold up in real patients, not just in lab measurements. Professional groups like the American Academy of Neurology had previously raised concerns about generic substitution for seizure medications, but this trial supported the safety of switching.
The Price Gap Is Significant
The practical reason most people end up on generic lamotrigine is cost. Without insurance, 100 tablets of brand-name Lamictal (100 mg) runs roughly $1,124. The same quantity of generic lamotrigine costs about $18. That’s a difference of more than 60 to 1. Most insurance plans and pharmacies will automatically substitute the generic unless your prescriber specifically requests the brand.
Where They Do Differ: Inactive Ingredients
The active drug is identical, but the inactive ingredients (fillers, binders, dyes, and flavorings) can vary between manufacturers. Brand-name Lamictal tablets contain lactose, microcrystalline cellulose, povidone, and sodium starch glycolate, along with specific colorants depending on the dose. The 100 mg tablet uses FD&C Yellow No. 6, the 150 mg uses yellow iron oxide, and the 200 mg uses FD&C Blue No. 2. The chewable version includes blackcurrant flavoring and saccharin sodium.
Generic versions use their own combinations of inactive ingredients, which may differ from Lamictal and from each other. For most people, this makes no practical difference. But if you have a known allergy or sensitivity to a specific dye, filler, or lactose, it’s worth checking the ingredient list on whichever version you’re dispensed. Your pharmacist can provide this information for the specific generic manufacturer they carry.
Available Forms
Both brand and generic lamotrigine come in several formats: standard tablets, chewable dispersible tablets, orally disintegrating tablets, and extended-release tablets. The extended-release version (branded as Lamictal XR) is designed to be taken once daily rather than twice, which some people find more convenient. Generic extended-release lamotrigine is also available, though it has been studied in children with partial seizures only down to age 13, while the standard formulations are approved for epilepsy in children as young as 2.
One Risk That Applies to Both
Because Lamictal and generic lamotrigine contain the same drug, they carry the same safety profile. The most notable risk is a serious skin reaction called Stevens-Johnson syndrome (SJS), which is rare but potentially life-threatening. In clinical trials, it occurred in about 0.1% of adults and 0.5% of children under 16. A broader post-marketing study found a rate of roughly 1.1 per 1,000 patients. The risk is highest during the first several weeks of treatment, which is why doctors increase the dose gradually. Any new rash that develops after starting lamotrigine, regardless of whether it’s brand or generic, should be evaluated promptly.
Children face a higher rate of serious skin reactions than adults. In trials, about 1% of pediatric patients developed a rash serious enough to require hospitalization, compared to 0.3% of adults.